is mounjaro a glp 1 drug FDA approves new version of diabetes to be sold for weight loss Mounjaro (tirzepatide): Uses, Side Effects,

Exclusion criteria for all groups included current or previous psychiatric comorbidities as diagnosed by DSM-5, using a structured interview (The Structured Clinical Interview for DSM-5, SCID-5) [28] if deemed relevant by the investigator, any general medical conditions known to influence energy processing and/or linked to fatigue, current treatment with any medication/supplementation likely to interfere with energy metabolism if deemed relevant by the investigator, contra-indications to magnetic resonance (MR) imaging, pregnancy or breast feeding

3 6 3

We list both products so patients can find honest information, not because we promote either one

doi: 10.3390/foods10040721 100